Procaps Group S.A. (NASDAQ:PROC – Get Free Report) shares were down 2% during trading on Wednesday . The stock traded as low as $1.96 and last traded at $1.96. Approximately 514 shares changed hands during mid-day trading, a decline of 96% from the average daily volume of 12,559 shares. The stock had previously closed at $2.00.
Procaps Group Stock Performance
The business has a 50 day moving average of $2.31 and a two-hundred day moving average of $2.69. The stock has a market capitalization of $221.13 million, a PE ratio of 3.77 and a beta of 0.16.
About Procaps Group
Procaps Group SA develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory.
Further Reading
- Five stocks we like better than Procaps Group
- The How and Why of Investing in Gold Stocks
- BHP Stock: The Under-the-Radar Growth Story in Commodities
- How Technical Indicators Can Help You Find Oversold StocksÂ
- Analysts Upgrade These 3 Hot Buy-and-Hold Stocks
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Kohl’s Charts a Resilient Path in a Challenging Retail Landscape
Receive News & Ratings for Procaps Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procaps Group and related companies with MarketBeat.com's FREE daily email newsletter.
